The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.
The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.
Patent No.:
Date of Patent:
Feb. 03, 2015
Filed:
Mar. 04, 2014
Applicants:
Holger Wagner, Mettenberg, DE;
Elke Langkopf, Biberach an der Riss, DE;
Frank Himmelsbach, Mittelbiberach, DE;
Rolf Goeggel, Ulm, DE;
Birgit Jung, Laupheim, DE;
Inventors:
Holger Wagner, Mettenberg, DE;
Elke Langkopf, Biberach an der Riss, DE;
Frank Himmelsbach, Mittelbiberach, DE;
Rolf Goeggel, Ulm, DE;
Birgit Jung, Laupheim, DE;
Assignee:
Boehringer Ingelheim International GmbH, Ingelheim am Rhein, DE;
Attorneys:
Primary Examiner:
Int. Cl.
CPC ...
C07D 213/30 (2006.01); C07D 401/06 (2006.01); C07D 413/06 (2006.01); A61K 31/44 (2006.01); A61K 31/4427 (2006.01); A61P 11/00 (2006.01); A61P 11/06 (2006.01); C07D 403/04 (2006.01); C07D 213/68 (2006.01); C07D 213/74 (2006.01); C07D 213/89 (2006.01); C07D 239/42 (2006.01); C07D 401/04 (2006.01); C07D 401/12 (2006.01); C07D 239/24 (2006.01); C07D 239/34 (2006.01); C07D 239/46 (2006.01); C07D 239/47 (2006.01); A61K 31/505 (2006.01); A61K 31/506 (2006.01);
U.S. Cl.
CPC ...
C07D 403/04 (2013.01); C07D 213/68 (2013.01); C07D 213/74 (2013.01); C07D 213/89 (2013.01); C07D 239/34 (2013.01); C07D 239/46 (2013.01); C07D 239/42 (2013.01); C07D 401/04 (2013.01); C07D 401/06 (2013.01); C07D 401/12 (2013.01);
Abstract
Heteroaryloxy-substituted benzoic acid amides of general formula I wherein the groups Rto Ras well as X and Y are defined according to claim, including the tautomers, the stereoisomers, the mixtures and the salts thereof. The compounds according to the invention are suitable for the treatment of respiratory complaints, particularly COPD and asthma.